Funding for this research was provided by:
national heart, lung, and blood institute (HL142251, HL145534-01)
u.s. department of defense (W81XWH1810380)
Article History
Received: 23 July 2021
Accepted: 12 August 2021
First Online: 4 September 2021
Declarations
:
: F.S. is a co-founder of Papillon Therapeutics Inc.